Professor Matthias Hentze

The role of the KSHI Advisory Committee is to advise, assist, and support the KSHI to ensure that it is well-established and well-resourced with the needed expertise and materials to create an innovation platform that is able to attract highly qualified academics, scientists, and clinicians as well as to establish world-class training programs and a network of stakeholders (including universities, hospitals, industry, and start-ups) to drive precision medicine and to address the Kingdom’s current gaps in clinical care and research and development (R&D).

Professor Matthias Hentze

Advisory Committee board members

Member | Director, European Molecular Biology Laboratory (EMBL)


  • Director, European Molecular Biology Laboratory (EMBL)
  • Professor (apl.), Medical Faculty, Ruprecht-Karls-University Heidelberg
  • Co-Director “Molecular Medicine Partnership Unit”, University of Heidelberg/EMBL, Heidelberg, Germany
  • Group Leader, EMBL, Heidelberg, Germany

Professional Profile

Matthias Hentze is currently the Director of the European Molecular Biology Laboratory (EMBL) and Co-Director of the Molecular Medicine Partnership Unit (MMPU) in Heidelberg (Germany). Following medical studies in Germany and the UK, and his qualification as a medical doctor, he obtained his postdoctoral training at the NIH (USA) in the late 1980s, when he and his colleagues discovered “iron-responsive elements” as the first mammalian regulatory elements in mature mRNAs. After two decades of elucidating mechanisms of RNA regulation by RNA-binding proteins, recent work by the Hentze group has uncovered hundreds of new RNA-binding proteins, including many metabolic enzymes. Supported by an ERC Advanced Grant and other funds, their current work uncovers new roles of RNA in riboregulation and elucidates connections between metabolism and gene regulation. 


Prof. Hentze is a co-founder of the MMPU, a joint interdisciplinary and translational research unit of the Medical Faculty of Heidelberg University and the EMBL, which bridges between medicine and molecular biology. Matthias Hentze’s research contributions have been recognized in numerous ways including Germany’s most prestigious scientific award, the Gottfried Wilhelm Leibniz Prize in 2000, the 2007 Lautenschläger Research Prize of Heidelberg University, and the 2015 Feodor Lynen Medal of the German Society for Biochemistry and Molecular Biology. He is also the 2020 recipient of the Lifetime Achievement Award of the RNA Society. He received an honorary doctorate by the Australian National University in Canberra, and is an elected member of the European Molecular Biology Organisation (EMBO), the German Academy of Sciences Leopoldina, and the Academia Europaea. In 2016, he became the first German scientist elected as a Corresponding Member of the Australian Academy of Science, and in 2018 he was elected into the American Academy of Arts and Sciences as an International Honorary Member. He was a co-founder of Anadys Pharmaceuticals (San Diego) and serves on numerous international scientific advisory and editorial boards. In 2020, he initiated the Environmental Research Initiative and Fund at EMBL.